Funded Grants

PI Name Sort descending PI Organization Title Grant Number Initiative Program Official
Saphner, Thomas J

Aurora Health Care, Inc.
United States

Aurora NCORP Community Site 5UG1CA190140-10 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Sariol, Carlos A

University Of Puerto Rico Med Sciences
United States

SARS-CoV-2 correlates of protection in a Latino-origin population 3U01CA260541-02S1 Guillermo Marquez, Ph.D.
Schallenkamp, John M.

Montana Cancer Consortium
United States

Montana Cancer Consortium: An Inclusive and Collaborative Approach to Clinical Trial Accrual and Cancer Care Delivery Research across Montana, Idaho and Wyoming 5UG1CA189872-10 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Schedin, Pepper J

Oregon Health & Science University
United States

NSAIDs During Postpartum Involution for Breast Cancer Chemoprevention 5R01CA169175-11
Schloss, Patrick David

University Of Michigan At Ann Arbor
United States

muMS2: an open source R package for analyzing and integrating multi-omics datasets to improve early detection and understanding of colorectal cancer 5U01CA264071-02 RFA-CA-21-014 (U01 Clinical Trial Optional)
Schmidt, Christian Maximillian

Indiana Univ-Purdue Univ At Indianapolis
United States

Longitudinal Proteomic and Metabolomic Predictors of Pancreatic Cyst Malignant Progression and Early Stage Pancreatic Cancer 5U01CA239522-04 PAR-18-913 (U01 Clinical Trial Not Allowed)
Schmit, Stephanie L

Cleveland Clinic Lerner Com-Cwru
United States

Variation in tumor-associated immune profiles and colorectal cancer outcomes 5R01CA248931-03
Schoen, Robert E.

University Of Pittsburgh At Pittsburgh
United States

Blood-Based Testing for Advanced Adenoma 5U01CA271884-02 RFA-CA-21-033 (U01 Clinical Trial Optional)
Schroeck, Florian R

Veterans Education/Res/Assn/North/Ne
United States

Replacing Invasive Cystoscopy with Urine Testing for Non-muscle Invasive Bladder Cancer Surveillance 1R37CA275916-01 Claire Zhu, Ph.D.
Sears, Rosalie C

Oregon Health & Science University
United States

Validation of novel imaging and molecular tests for early detection of pancreatic cancer through risk-stratified community engagement programs 1U01CA278923-01 Matthew Young, Ph.D.